Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mackness

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Biochemistry|September 14, 2013
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndromeNatàlia Ferré, Albert Feliu, Anabel García-Heredia, et al.
Clinical Biochemistry|August 23, 2011
Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver diseaseAnabel García-Heredia, Judit Marsillach, Gerard Aragonès, et al.
Clinical Biochemistry|March 6, 2007
Serum paraoxonase-1 in chronic alcoholics: relationship with liver diseaseJudit Marsillach, Natàlia Ferré, Maria C Vila, et al.
Journal of Proteome Research|March 2, 2013
Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approachAnabel García-Heredia, Elizabeth Kensicki, Robert P Mohney, et al.
Atherosclerosis|December 14, 2011
Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery diseaseAnna Rull, Raúl García, Laura Fernández-Sender, et al.
Journal of Lipid Research|October 18, 2011
Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidationGerard Aragonès, Anabel García-Heredia, Marta Guardiola, et al.
Journal of Lipid Research|March 9, 2013
Paraoxonase-1 status in patients with hereditary hemochromatosisNicola Martinelli, Anabel García-Heredia, Helena Roca, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Biochemistry|September 14, 2013
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndromeNatàlia Ferré, Albert Feliu, Anabel García-Heredia, et al.
Clinical Biochemistry|August 23, 2011
Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver diseaseAnabel García-Heredia, Judit Marsillach, Gerard Aragonès, et al.
Clinical Biochemistry|March 6, 2007
Serum paraoxonase-1 in chronic alcoholics: relationship with liver diseaseJudit Marsillach, Natàlia Ferré, Maria C Vila, et al.
Journal of Proteome Research|March 2, 2013
Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approachAnabel García-Heredia, Elizabeth Kensicki, Robert P Mohney, et al.
Atherosclerosis|December 14, 2011
Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery diseaseAnna Rull, Raúl García, Laura Fernández-Sender, et al.
Journal of Lipid Research|October 18, 2011
Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidationGerard Aragonès, Anabel García-Heredia, Marta Guardiola, et al.
Journal of Lipid Research|March 9, 2013
Paraoxonase-1 status in patients with hereditary hemochromatosisNicola Martinelli, Anabel García-Heredia, Helena Roca, et al.
Pageof 3